(KN) Knowles Cor - Ratings and Ratios
Capacitors, RF Filters, Balanced Armature Speakers, Medtech Microphones
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 33.3% |
| Value at Risk 5%th | 46.5% |
| Relative Tail Risk | -15.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.35 |
| Alpha | -12.50 |
| CAGR/Max DD | 0.23 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.386 |
| Beta | 1.436 |
| Beta Downside | 1.243 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.00% |
| Mean DD | 13.81% |
| Median DD | 13.86% |
Description: KN Knowles Cor November 12, 2025
Knowles Corporation (NYSE:KN) manufactures high-performance capacitors, RF/microwave filters, balanced-armature speakers and med-tech microphones, serving OEMs and distributors across defense, medical, electric-vehicle (EV), industrial and communications markets. The business is split into two segments: Precision Devices (PD), which supplies ceramic, film, electrolytic and mica capacitors plus RF filtering for power supplies, medical implants, satellite communications and radar; and Medtech & Specialty Audio (MSA), which produces balanced-armature speakers and microphones for hearing-health, consumer audio and true-wireless stereo applications. The company, founded in 1946, is headquartered in Itasca, Illinois and operates globally in Asia, the United States, Europe and the rest of the Americas.
Key operating metrics from the FY2023 Form 10-K show total revenue of approximately $1.73 billion, with the PD segment contributing roughly 58 % of sales and delivering a segment operating margin of 16 % versus 12 % for MSA. R&D intensity remains high at ~9 % of revenue, reflecting the need to stay ahead in miniaturization and RF performance. Demand drivers include the rollout of 5G infrastructure (boosting RF filter volumes), the accelerating EV power-train electrification (increasing capacitor consumption), and the aging-population-driven growth in hearing-aid devices, which together underpin a projected 5-year CAGR of 6-8 % for the company’s core end-markets.
For a deeper, data-driven assessment of Knowles’ valuation and risk profile, you may find the analyst tools on ValueRay useful for building a more granular financial model.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (39.3m TTM) > 0 and > 6% of Revenue (6% = 34.4m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -4.44pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 27.59% (prev 45.46%; Δ -17.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 101.9m > Net Income 39.3m (YES >=105%, WARN >=100%) |
| Net Debt (104.5m) to EBITDA (95.6m) ratio: 1.09 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (87.3m) change vs 12m ago -2.68% (target <= -2.0% for YES) |
| Gross Margin 40.77% (prev 39.97%; Δ 0.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 50.76% (prev 46.97%; Δ 3.79pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.41 (EBITDA TTM 95.6m / Interest Expense TTM 10.9m) >= 6 (WARN >= 3) |
Altman Z'' -2.71
| (A) 0.15 = (Total Current Assets 334.2m - Total Current Liabilities 176.0m) / Total Assets 1.09b |
| (B) -0.54 = Retained Earnings (Balance) -590.4m / Total Assets 1.09b |
| (C) 0.05 = EBIT TTM 59.0m / Avg Total Assets 1.13b |
| (D) -2.14 = Book Value of Equity -718.6m / Total Liabilities 336.4m |
| Total Rating: -2.71 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.94
| 1. Piotroski 8.0pt |
| 2. FCF Yield 3.85% |
| 3. FCF Margin 14.26% |
| 4. Debt/Equity 0.26 |
| 5. Debt/Ebitda 1.09 |
| 6. ROIC - WACC (= -5.33)% |
| 7. RoE 5.22% |
| 8. Rev. Trend -67.98% |
| 9. EPS Trend -46.39% |
What is the price of KN shares?
Over the past week, the price has changed by +2.69%, over one month by -3.76%, over three months by -4.73% and over the past year by +13.04%.
Is KN a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the KN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.5 | 17.6% |
| Analysts Target Price | 26.5 | 17.6% |
| ValueRay Target Price | 22.7 | 0.8% |
KN Fundamental Data Overview January 08, 2026
P/E Forward = 11.9332
P/S = 3.5224
P/B = 2.536
P/EG = 1.12
Beta = 1.503
Revenue TTM = 573.5m USD
EBIT TTM = 59.0m USD
EBITDA TTM = 95.6m USD
Long Term Debt = 104.0m USD (from longTermDebt, last quarter)
Short Term Debt = 76.1m USD (from shortTermDebt, last quarter)
Debt = 197.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 104.5m USD (from netDebt column, last quarter)
Enterprise Value = 2.12b USD (2.02b + Debt 197.0m - CCE 92.5m)
Interest Coverage Ratio = 5.41 (Ebit TTM 59.0m / Interest Expense TTM 10.9m)
FCF Yield = 3.85% (FCF TTM 81.8m / Enterprise Value 2.12b)
FCF Margin = 14.26% (FCF TTM 81.8m / Revenue TTM 573.5m)
Net Margin = 6.85% (Net Income TTM 39.3m / Revenue TTM 573.5m)
Gross Margin = 40.77% ((Revenue TTM 573.5m - Cost of Revenue TTM 339.7m) / Revenue TTM)
Gross Margin QoQ = 43.23% (prev 40.85%)
Tobins Q-Ratio = 1.95 (Enterprise Value 2.12b / Total Assets 1.09b)
Interest Expense / Debt = 1.17% (Interest Expense 2.30m / Debt 197.0m)
Taxrate = 19.28% (4.30m / 22.3m)
NOPAT = 47.6m (EBIT 59.0m * (1 - 19.28%))
Current Ratio = 1.90 (Total Current Assets 334.2m / Total Current Liabilities 176.0m)
Debt / Equity = 0.26 (Debt 197.0m / totalStockholderEquity, last quarter 751.8m)
Debt / EBITDA = 1.09 (Net Debt 104.5m / EBITDA 95.6m)
Debt / FCF = 1.28 (Net Debt 104.5m / FCF TTM 81.8m)
Total Stockholder Equity = 752.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.48% (Net Income 39.3m / Total Assets 1.09b)
RoE = 5.22% (Net Income TTM 39.3m / Total Stockholder Equity 752.4m)
RoCE = 6.89% (EBIT 59.0m / Capital Employed (Equity 752.4m + L.T.Debt 104.0m))
RoIC = 5.06% (NOPAT 47.6m / Invested Capital 941.8m)
WACC = 10.39% (E(2.02b)/V(2.22b) * Re(11.31%) + D(197.0m)/V(2.22b) * Rd(1.17%) * (1-Tc(0.19)))
Discount Rate = 11.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.89%
[DCF Debug] Terminal Value 71.05% ; FCFF base≈105.1m ; Y1≈110.3m ; Y5≈128.8m
Fair Price DCF = 16.88 (EV 1.54b - Net Debt 104.5m = Equity 1.44b / Shares 85.2m; r=10.39% [WACC]; 5y FCF grow 5.32% → 3.0% )
EPS Correlation: -46.39 | EPS CAGR: -51.19% | SUE: -4.0 | # QB: 0
Revenue Correlation: -67.98 | Revenue CAGR: -10.76% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=-0.050 | Revisions Net=-4 | Analysts=4
EPS next Year (2026-12-31): EPS=1.22 | Chg30d=-0.010 | Revisions Net=-1 | Growth EPS=+11.6% | Growth Revenue=+5.9%
Additional Sources for KN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle